{"text": "slrn pricing 30 4 5 m shares 18 higher end of range fully diluted share count assuming overallotment would be gt 105m shares putting valuation gt 1 9b for an il 17a in p2 3 igf 1r currently in mad c kit mab preclinical vrdn amgn hznp mltx"}
{"text": "nvo lly pfe amgn amp vktx mentioned but only one not covered viking therapeuticss vktx not covered vk2735 dual glp 1 gip agonist for obesity vk2809 tr agonist for nash wednesday june 28 12 15 pm et"}
{"text": "horizon pharma gains on report about amgen potential deal close on may 23 hznp amgn"}
{"text": "hznp amgn horizon pharma gains on report about amgen potential deal close on may 23 dealrep"}
{"text": "amgn hznp horizon pharma gains on report about amgen potential deal close on may 23"}
{"text": "amgn qcom meta rblx let s see what freaky friday brings thestrat optionstrading stocks"}
